Table 5 Risk of SPM after lung HGNEC, stratified by age
Observed | Expected | O/E | 95% CI | Excess risk | |
|---|---|---|---|---|---|
< 50 years | |||||
All Sites | 31 | 8.26 | 3.75 | 2.55–5.33 | 87.27 |
All Solid Tumours | 28 | 7.44 | 3.76 | 2.5–5.44 | 78.9 |
Oral cavity and pharynx | 2 | 0.25 | 8.07 | 0.98–29.16 | 6.72 |
Floor of Mouth | 1 | 0.01 | 81.76 | 2.07–455.51 | 3.79 |
Gum and Other Mouth | 1 | 0.02 | 40.99 | 1.04–228.4 | 3.74 |
Digestive System | 8 | 1.2 | 6.66 | 2.88–13.12 | 26.09 |
Colon, Rectum and Anus | 3 | 0.72 | 4.14 | 0.85–12.1 | 8.73 |
Pancreas | 5 | 0.12 | 41.88 | 13.6–97.74 | 18.73 |
Respiratory System | 7 | 0.56 | 12.41 | 4.99–25.58 | 24.7 |
Lung and Bronchus | 7 | 0.49 | 14.22 | 5.72–29.3 | 24.97 |
Miscellaneous | 2 | 0.09 | 21.21 | 2.57–76.62 | 7.31 |
50–64 years | |||||
All Sites | 394 | 214.04 | 1.84 | 1.66–2.03 | 82.14 |
All Solid Tumours | 361 | 194.61 | 1.86 | 1.67–2.06 | 75.95 |
Oral cavity and pharynx | 13 | 6.26 | 2.08 | 1.11–3.55 | 3.08 |
Floor of Mouth | 3 | 0.37 | 8.13 | 1.68–23.76 | 1.2 |
Pharynx | 4 | 0.92 | 4.35 | 1.18–11.13 | 1.41 |
Oropharynx | 4 | 0.27 | 14.73 | 4.01–37.71 | 1.7 |
Digestive System | 62 | 36.56 | 1.7 | 1.3–2.17 | 11.61 |
Esophagus | 7 | 2.14 | 3.27 | 1.31–6.73 | 2.22 |
Small Intestine | 4 | 1.04 | 3.83 | 1.04–9.81 | 1.35 |
Ascending Colon | 6 | 1.93 | 3.11 | 1.14–6.77 | 1.86 |
Pancreas | 17 | 4.97 | 3.42 | 1.99–5.48 | 5.49 |
Respiratory System | 186 | 27.27 | 6.82 | 5.88–7.88 | 72.45 |
Lung and Bronchus | 180 | 24.94 | 7.22 | 6.2–8.35 | 70.77 |
Male Genital System | 15 | 36.56 | 0.41 | 0.23–0.68 | −9.84 |
Prostate | 14 | 36.09 | 0.39 | 0.21–0.65 | −10.08 |
Urinary System | 32 | 14.84 | 2.16 | 1.47–3.04 | 7.83 |
Urinary Bladder | 15 | 6.92 | 2.17 | 1.21–3.57 | 3.69 |
Kidney | 17 | 7.4 | 2.3 | 1.34–3.68 | 4.38 |
All Lymphatic and Hematopoietic Diseases | 28 | 15.75 | 1.78 | 1.18–2.57 | 5.59 |
Leukemia | 24 | 4.52 | 5.32 | 3.41–7.91 | 8.89 |
Acute Lymphocytic Leukemia | 3 | 0.24 | 12.48 | 2.57–36.48 | 1.26 |
Non-Lymphocytic Leukemia | 18 | 2.08 | 8.67 | 5.14–13.7 | 7.27 |
Acute Non-Lymphocytic Leukemia | 16 | 1.36 | 11.75 | 6.72–19.08 | 6.68 |
Myeloid and Monocytic Leukemia | 18 | 1.94 | 9.29 | 5.51–14.68 | 7.33 |
Acute Myeloid Leukemia | 14 | 1.23 | 11.4 | 6.23–19.13 | 5.83 |
Acute Monocytic Leukemia | 2 | 0.08 | 24.43 | 2.96–88.23 | 0.88 |
> 65 years | |||||
All Sites | 936 | 665.19 | 1.41 | 1.32–1.5 | 83.43 |
All Solid Tumours | 852 | 588.37 | 1.45 | 1.35–1.55 | 81.22 |
Oral cavity and pharynx | 15 | 13.55 | 1.11 | 0.62–1.83 | 0.45 |
Floor of Mouth | 4 | 0.73 | 5.48 | 1.49–14.04 | 1.01 |
Digestive System | 157 | 127.41 | 1.23 | 1.05–1.44 | 9.12 |
Colon, Rectum and Anus | 97 | 67.29 | 1.44 | 1.17–1.76 | 9.15 |
Colon and Rectum | 91 | 65.22 | 1.4 | 1.12–1.71 | 7.94 |
Colon excluding Rectum | 77 | 49.1 | 1.57 | 1.24–1.96 | 8.6 |
Ascending Colon | 22 | 10.23 | 2.15 | 1.35–3.25 | 3.62 |
Respiratory System | 457 | 117.15 | 3.9 | 3.55–4.28 | 104.7 |
Lung and Bronchus | 440 | 111.17 | 3.96 | 3.6–4.35 | 101.3 |
Breast | 49 | 82.13 | 0.6 | 0.44–0.79 | −10.21 |
Female Genital System | 10 | 30.69 | 0.33 | 0.16–0.6 | −6.37 |
Corpus and Uterus, NOS | 2 | 17.05 | 0.12 | 0.01–0.42 | −4.64 |
Male Genital System | 44 | 107.8 | 0.41 | 0.3–0.55 | −19.65 |
Prostate | 43 | 106.87 | 0.4 | 0.29–0.54 | −19.68 |
Urinary System | 83 | 60.72 | 1.37 | 1.09–1.69 | 6.86 |
All Lymphatic and Hematopoietic Diseases | 66 | 59.42 | 1.11 | 0.86–1.41 | 2.03 |
Leukemia | 42 | 18.82 | 2.23 | 1.61–3.02 | 7.14 |
Non-Lymphocytic Leukemia | 37 | 9.31 | 3.97 | 2.8–5.48 | 8.53 |
Acute Non-Lymphocytic Leukemia | 34 | 6.31 | 5.39 | 3.73–7.53 | 8.53 |
Myeloid and Monocytic Leukemia | 37 | 8.44 | 4.39 | 3.09–6.04 | 8.8 |
Acute Myeloid Leukemia | 32 | 5.66 | 5.65 | 3.87–7.98 | 8.11 |